Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 1
2000 1
2002 1
2004 3
2005 1
2006 4
2007 3
2008 4
2009 3
2010 6
2011 2
2012 4
2013 7
2014 8
2015 7
2016 2
2017 2
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 28440968

56 results
Results by year
Filters applied: . Clear all
Page 1
The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy.
Suknikhom W, Lertkhachonsuk R, Manchana T. Suknikhom W, et al. Asian Pac J Cancer Prev. 2017 Mar 1;18(3):633-638. doi: 10.22034/APJCP.2017.18.3.633. Asian Pac J Cancer Prev. 2017. PMID: 28440968 Free PMC article.
Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.
Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Ito T, et al. Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10. Nutr Cancer. 2014. PMID: 24611562 Clinical Trial.
Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults.
Yin Z, Fujii H, Walshe T. Yin Z, et al. Hum Immunol. 2010 Dec;71(12):1187-90. doi: 10.1016/j.humimm.2010.08.006. Epub 2010 Aug 21. Hum Immunol. 2010. PMID: 20732368
Effect of active hexose-correlated compound in women receiving adjuvant chemotherapy for breast cancer: a retrospective study.
Hangai S, Iwase S, Kawaguchi T, Kogure Y, Miyaji T, Matsunaga T, Nagumo Y, Yamaguchi T. Hangai S, et al. J Altern Complement Med. 2013 Nov;19(11):905-10. doi: 10.1089/acm.2012.0914. Epub 2013 Jul 5. J Altern Complement Med. 2013. PMID: 23829813 Free PMC article.
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
Yanagimoto H, Satoi S, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y, Tsuta K, Kon M. Yanagimoto H, et al. Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4. Nutr Cancer. 2016. PMID: 26847832 Clinical Trial.
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784
Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.
Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Gao Y, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. doi: 10.1007/s00262-005-0111-9. Epub 2005 Dec 16. Cancer Immunol Immunother. 2006. PMID: 16362410
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.
Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W. Cowawintaweewat S, et al. Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45. Asian Pac J Allergy Immunol. 2006. PMID: 16913187 Free article. Clinical Trial.
Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice.
Cao Z, Chen X, Lan L, Zhang Z, Du J, Liao L. Cao Z, et al. Nutr Res Pract. 2015 Apr;9(2):129-36. doi: 10.4162/nrp.2015.9.2.129. Epub 2014 Dec 26. Nutr Res Pract. 2015. PMID: 25861418 Free PMC article.
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Shigama K, et al. J Exp Ther Oncol. 2009;8(1):43-51. J Exp Ther Oncol. 2009. PMID: 19827270
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page